These results indicated that HMGB1 and RICTOR mRNAs epigenetically promote the activation of the AKT-mTOR signaling pathway and glutamine metabolism in HCC depending on the miR-200 family binding sites in 3′UTR. The gene discussed is RICTOR; the disease is hepatocellular carcinoma.